The dosage market size for Penicillins and Streptomycins in Italy exhibited a gradual decline in value per capita from 2013 to 2023, settling at $11.76 in 2023. Notably, from 2014 to 2023, the market saw fluctuations with an overall decrease, but witnessed a modest stability from 2016 to 2023 with a minor annual decrease rate.
Year-on-year analysis demonstrates a decline of approximately 0.68% from 2022 to 2023, and a CAGR of approximately -0.53% over the last five years, reflecting a slightly contracting market.
Looking ahead, key trends to watch include potential market stabilizers such as emerging generic alternatives, government healthcare policies, and shifts in consumer preferences and healthcare practices that could influence both the demand and pricing of these antibiotics.
